1,042
Views
49
CrossRef citations to date
0
Altmetric
Research Article

Surgery for skeletal metastases in lung cancer

Complications and survival in 98 patients

&
Pages 96-101 | Received 30 Apr 2010, Accepted 17 Sep 2010, Published online: 01 Feb 2011

  • Agarwala AK, Hanna NH. Long-term survival in a patient with stage IV non-small-cell lung carcinoma after bone metastasectomy. Clin Lung Cancer 2005; 6:367-8.
  • Atanasiu JP, Badatcheff F, Pidhorz L. Metastatic lesions of the cervical spine. A retrospective analysis of 20 cases. Spine (Phila Pa 1976) 1993; 18:1279-84.
  • Bauer HC, Wedin R. Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand 1995; 66:143-6.
  • Bohm P, Huber J. The surgical treatment of bony metastases of the spine and limbs. J Bone Joint Surg (Br) 2002; 84:521-9.
  • Bono B, Cazzaniga P, Pini V, Zurrida SM, Spagnolo R, Torelli L, Corona C, Bono A. Palliative surgery of metastatic bone disease: a review of 83 cases. Eur J Cancer 1991; 27:556-8.
  • Boyle P, Dresler C. Preventing the lung cancer epidemic. Ann Oncol 2005; 16:1565-6.
  • Coleman RE. Skeletal complications of malignancy. Cancer 1997; 80:1588-94.
  • Cybulski GR, Von Roenn KA, D'Angelo CM, DeWald RL. Luque rod stabilization for metastatic disease of the spine. Surg Neurol 1987; 28:277-83.
  • Davis LA, Warren SA, Reid DC, Oberle K, Saboe LA, Grace MG. Incomplete neural deficits in thoracolumbar and lumbar spine fractures. Reliability of Frankel and Sunnybrook scales. Spine (Phila Pa 1976) 1993; 18:257-63.
  • Durr HR, Refior HJ. Prognosis of skeletal metastases. Orthopade 1998, 27: 294-300.
  • Frankel HL, Hancock DO, Hyslop G, Melzak J, Michaelis LS, Ungar GH, Vernon JD, Walsh JJ. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I. Paraplegia 1969; 7:179-92.
  • Giaccone G, Gallegos Ruiz M, Le Chevalier T, Thatcher N, Smit E, Rodriguez JA, Janne P, Oulid-Aissa D, Soria JC. Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study. Clin Cancer Res 2006; 12:6049-55.
  • Hansen BH, Keller J, Laitinen M, Berg P, Skjeldal S, Trovik C, Nilsson J, Walloe A, Kalen A, Wedin R. The Scandinavian Sarcoma Group Skeletal Metastasis Register. Survival after surgery for bone metastases in the pelvis and extremities. Acta Orthop Scand (Suppl 311) 2004, 75: 11-5.
  • Harrington KD, Sim FH, Enis JE, Johnston JO, Diok HM, Gristina AG. Methylmethacrylate as an adjunct in internal fixation of pathological fractures. Experience with three hundred and seventy-five cases. J Bone Joint Surg (Am) 1976; 58:1047-55.
  • Hirano Y, Oda M, Tsunezuka Y, Ishikawa N, Watanabe G. Long-term survival cases of lung cancer presented as solitary bone metastasis. Ann Thorac Cardiovasc Surg 2005, 11: 401-4.
  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225-49.
  • Katagiri H, Takahashi M, Wakai K, Sugiura H, Kataoka T, Nakanishi K. Prognostic factors and a scoring system for patients with skeletal metastasis. J Bone Joint Surg (Br) 2005; 87:698-703.
  • Langer C, Hirsh V. Skeletal morbidity in lung cancer patients with bone metastases: demonstrating the need for early diagnosis and treatment with bisphosphonates. Lung Cancer 2010; 67:4-11.
  • Lin PP, Mirza AN, Lewis VO, Cannon CP, Tu SM, Tannir NM, Yasko AW. Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg (Am) 2007; 89:1794-801.
  • Matzkin H, Perito PE, Soloway MS. Prognostic factors in metastatic prostate cancer. Cancer 1993; 72:3788-92.
  • Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111:1710-7.
  • Nathan SS, Healey JH, Mellano D, Hoang B, Lewis I, Morris CD, Athanasian EA, Boland PJ. Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol 2005; 23:6072-82.
  • Rosen LS, Gordon D, Tchekmedyian S, Yanagihara R, Hirsh V, Krzakowski M, Pawlicki M, de Souza P, Zheng M, Urbanowitz G, Reitsma D, Seaman JJ. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial–the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol 2003; 21:3150-7.
  • Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006; 355:2542-50.
  • Sugiura H, Yamada K, Sugiura T, Hida T, Mitsudomi T. Predictors of survival in patients with bone metastasis of lung cancer. Clin Orthop 2008; (466):729-36.
  • Tomita K, Kawahara N, Baba H, Tsuchiya H, Nagata S, Toribatake Y. Total en bloc spondylectomy for solitary spinal metastases. Int Orthop 1994; 18:291-8.
  • Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 2001; 26:298-306.
  • Wedin R, Bauer HC. Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail? J Bone Joint Surg (Br) 2005; 87:1653-7.
  • Wedin R, Bauer HC, Wersall P. Failures after operation for skeletal metastatic lesions of long bones. Clin Orthop 1999: (358): 128-39.
  • Wedin R, Bauer HC, Rutqvist LE. Surgical treatment for skeletal breast cancer metastases: a population-based study of 641 patients. Cancer 2001; 92:257-62.
  • Yazawa Y, Frassica FJ, Chao EY, Pritchard DJ, Sim FH, Shives TC. Metastatic bone disease. A study of the surgical treatment of 166 pathologic humeral and femoral fractures. Clin Orthop 1990; (251):213-9.